GLP-1 / metabolic
SLU-PP-332
Preclinical (animal)SLU-PP-332 · Pan-ERR agonist ('exercise mimetic')
Preclinical exercise-mimetic ERR agonist; mouse data only.
What it is
A small-molecule agonist of estrogen-related receptors that reproduces some transcriptional effects of aerobic exercise in muscle.
How it works
Activates ERRα/β/γ to upregulate mitochondrial biogenesis and fatty-acid oxidation, mimicking endurance adaptations.
Studied for
Endurance capacity, fat oxidation, metabolic health (preclinical).
Regulatory status
Not approved; research-use-only compound.
Safety
No human safety data whatsoever; toxicology unknown — not for human use.
What the community reports about SLU-PP-332
Aggregated from real community discussions across social platforms and forums. Anecdotal and self-reported — not causal, not medical advice.
The exercise mimetic. SLU-PP-332 is a small-molecule ERR agonist that tells the mitochondria to behave as if you just exercised — driving AMPK activation and fat oxidation, and building new mitochondria whose endurance benefit persists for weeks after stopping. It's an early-stage research compound (mostly animal data plus anecdote), available in oral and injectable forms, and cycled alongside the other mitochondrial/metabolic compounds.
- Exercise mimetic — tells mitochondria to act like you just trained
Aggregated from public discussions and community forums, synthesized into themes and counts. Anecdotal and self-reported — not causal, not evidence a compound is safe or effective, not medical advice, and not a recommendation to use. No dosing shown.
Educational information only — not medical advice, and not a recommendation to use any compound. Many peptides here are not approved for human use; legal status and evidence quality vary and are noted above. This page contains no dosing information. Consult a qualified clinician before making any health decision.